We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sorrento Tech Com USD0.001 (MM) | NASDAQ:ROKA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.65 | 0.64 | 0.67 | 0 | 01:00:00 |
ROKA BIOSCIENCE, INC.
|
(Name of Issuer)
|
|
COMMON STOCK
|
(Title of Class of Securities)
|
|
775431109
|
(CUSIP Number)
|
OrbiMed Advisors LLC
|
OrbiMed Capital GP III LLC
|
Samuel D. Isaly
|
|
601 Lexington Avenue, 54th Floor
|
New York, NY 10022
|
Telephone: (212) 739-6400
|
(Name, Address and Telephone Number of Person
|
Authorized to Receive Notices and Communications)
|
|
|
September 28, 2017
|
(Date of Event Which Requires Filing of this Statement)
|
CUSIP No. 775431109
|
|
|||
1
|
NAME OF REPORTING PERSON
OrbiMed Advisors LLC
|
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☐
|
||
3
|
SEC USE ONLY
|
|
||
4
|
SOURCE OF FUNDS
AF (See Item 3)
|
|
||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|
||
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
0
|
|
|
8
|
SHARED VOTING POWER
773,045*
|
|
||
9
|
SOLE DISPOSITIVE POWER
0
|
|
||
10
|
SHARED DISPOSITIVE POWER
773,045*
|
|
||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
773,045*
|
|
||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.86%
†
|
|
||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IA
|
|
*
|
Includes 571,428 shares of the Issuer’s Common Stock (the “
Shares
”) underlying warrants (the “
Warrants
”).
|
|
|
†
|
This percentage is calculated based on 5,007,742 outstanding Shares of the Issuer, as set forth in the Issuer’s Form 10-Q/A, filed with the Securities and Exchange Commission (the “
SEC
”) on September 28, 2017, and includes 571,428 Shares subject to currently exercisable Warrants.
|
CUSIP No. 775431109
|
|
|||
1
|
NAME OF REPORTING PERSON
OrbiMed Capital GP III LLC
|
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☐
|
||
3
|
SEC USE ONLY
|
|
||
4
|
SOURCE OF FUNDS
AF (See Item 3)
|
|
||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|
||
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
0
|
|
|
8
|
SHARED VOTING POWER
765,755*
|
|
||
9
|
SOLE DISPOSITIVE POWER
0
|
|
||
10
|
SHARED DISPOSITIVE POWER
765,755*
|
|
||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
765,755*
|
|
||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.74%
†
|
|
||
14
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
|
*
|
Includes 566,037 shares of the Issuer’s Common Stock (the “
Shares
”) underlying warrants (the “
Warrants
”).
|
|
|
†
|
This percentage is calculated based on 5,007,742 outstanding Shares of the Issuer, as set forth in the Issuer’s Form 10-Q/A, filed with the Securities and Exchange Commission (the “
SEC
”) on September 28, 2017, and includes 566,037 Shares subject to currently exercisable Warrants.
|
CUSIP No. 775431109
|
|
|||
1
|
NAME OF REPORTING PERSON
Samuel D. Isaly
|
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☐
|
||
3
|
SEC USE ONLY
|
|
||
4
|
SOURCE OF FUNDS
AF (See Item 3)
|
|
||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
|
||
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
0
|
|
|
8
|
SHARED VOTING POWER
773,045*
|
|
||
9
|
SOLE DISPOSITIVE POWER
0
|
|
||
10
|
SHARED DISPOSITIVE POWER
773,045*
|
|
||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
773,045*
|
|
||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.86%
†
|
|
||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
|
*
|
Includes 571,428 shares of the Issuer’s Common Stock (the “
Shares
”) underlying warrants (the “
Warrants
”).
|
|
|
†
|
This percentage is calculated based on 5,007,742 outstanding Shares of the Issuer, as set forth in the Issuer’s Form 10-Q/A, filed with the Securities and Exchange Commission (the “
SEC
”) on September 28, 2017, and includes 571,428 Shares subject to currently exercisable Warrants.
|
(i) |
name;
|
(ii) |
business address;
|
(iii) |
present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted;
|
(iv) |
citizenship.
|
Seller
|
Date of Transaction
|
Transaction
|
Number of Shares
|
Price Per Share*
|
|
OPI III
|
September 28, 2017
|
Sold
|
376,950
|
$0.72
|
|
Associates III
|
September 28, 2017
|
Sold
|
3,592
|
$0.72
|
|
OPI III
|
September 29, 2017
|
Sold
|
93,246
|
$0.74
|
|
Associates III
|
September 29, 2017
|
Sold
|
888
|
$0.74
|
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP III LLC and Samuel D. Isaly.
|
|
OrbiMed Advisors LLC
|
|||
|
||||
|
By:
|
/s/ Samuel D. Isaly
|
||
|
|
Name:
|
Samuel D. Isaly
|
|
|
|
Title:
|
Managing Member
|
|
|
|
|||
|
|
|||
|
OrbiMed Capital GP III LLC
|
|||
|
|
|||
|
By:
|
OrbiMed Advisors LLC
|
||
|
|
|||
|
|
|||
|
By:
|
/s/ Samuel D. Isaly
|
||
|
|
Name:
|
Samuel D. Isaly
|
|
|
|
Title:
|
Managing Member
|
|
|
|
|||
|
Samuel D. Isaly
|
|||
|
By:
|
/s/ Samuel D. Isaly
|
||
|
|
Name:
|
Samuel D. Isaly
|
|
Name
|
Position with Reporting
Person
|
Principal Occupation
|
Samuel D. Isaly
|
Managing Member
|
Managing Member
OrbiMed Advisors LLC
|
Carl L. Gordon
|
Member
|
Member
OrbiMed Advisors LLC
|
Sven H. Borho
German and Swedish Citizen
|
Member
|
Member
OrbiMed Advisors LLC
|
Jonathan T. Silverstein
|
Member
|
Member
OrbiMed Advisors LLC
|
W. Carter Neild
|
Member
|
Member
OrbiMed Advisors LLC
|
Geoffrey C. Hsu
|
Member
|
Member
OrbiMed Advisors LLC
|
Evan D. Sotiriou
|
Chief Financial Officer
|
Chief Financial Officer
OrbiMed Advisors LLC
|
Exhibit
|
Description
|
1.
|
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP III LLC and Samuel D. Isaly.
|
1 Year ROKA BIOSCIENCE, INC. Chart |
1 Month ROKA BIOSCIENCE, INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions